Drug Type Small molecule drug |
Synonyms Amlodipine/bisoprolol, Bisoprolol/amlodipine, Concor-AM + [3] |
Target |
Mechanism VDCCs blockers(Voltage-gated calcium channel blockers), β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date IN (01 Jan 2010), |
Regulation- |
Molecular FormulaC26H31ClN2O8S |
InChIKeyZPBWCRDSRKPIDG-UHFFFAOYSA-N |
CAS Registry111470-99-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | CN | 11 May 2021 | |
Essential Hypertension | IN | 01 Jan 2010 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Essential Hypertension | Preclinical | DE | 23 Feb 2014 | |
Hypertension | Discovery | CN | 09 Aug 2017 |
Phase 3 | 200 | (Amlodipine Failed Group) | qsjmdmcang(jmptnvsxne) = wbmfpangin zkmrevhury (jphfdcxqqq, flgwmtcnhb - zznksnxzfx) View more | - | 11 Aug 2016 | ||
(Bisoprolol Failed Group) | qsjmdmcang(jmptnvsxne) = anayewrmhu zkmrevhury (jphfdcxqqq, jtxdjhbulz - rbwieufapa) View more |